NCT02274480View on ClinicalTrials.gov

Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

October 22, 2014

Primary Completion Date

September 2, 2020

Study Completion Date

September 2, 2020

Conditions
Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients
Interventions
DEVICE

cardiac MRI with DWI

Trial Locations (2)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02274480 - Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity | Biotech Hunter | Biotech Hunter